Trial Profile
A Randomized, Open-Label, 3-Period Crossover, Single-Dose Clinical Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Beclomethasone Dipropionate (160 and 320 mcg) Delivered Via Breath-Actuated Inhaler (BAI) and Metered-Dose Inhaler (MDI) in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Teva Branded Pharmaceutical Products R&D
- 15 Feb 2017 New trial record